Rabindranath Tagore International Institute of Cardiac Sciences (RTIICS)

Name :

Rabindranath Tagore International Institute of Cardiac Sciences (RTIICS)

Address  :

124, Mukundapur, E.M.Bypass
Near Santoshpur Connector

Town  :

Kolkata

State  :

West Bengal

Country  :

INDIA

Post Code:

700 099

Phone  :

9133 2436 4000

Fax  :

91 33 2426 4204

Web URL  :

Email  :

Specialization
  • Anaesthesiology
  • Cardiology
  • Cardiothoracic Surgeon
  • Daibetes, Endocrinology
  • ENT
  • Gastro-enterology
  • General Surgeon
  • Gynaecology
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Ophthalmology
  • Orthopedics
  • Paediatrics
  • Plastic Surgery
  • Psychiatrist
  • Urology
  • Vascular Surgeon
Facilities

Total Number Of Beds : 445

Ambulance : 1

Ambulance Contact Number : 91 99033 35544


Description

Rabindranath Tagore International Institute of Cardiac Sciences RTIICS Kolkata is a 445Bed fullfledged multispecialty hospital built on approximately 4 acres of land The hospital comprises of Cardiac Centre the Armenian Church Trauma Centre Rotary Narayana Nethralaya Institute of Ophthalmology and Manjulaben Mehta Kidney Hospital

Mission
Rabindranath Tagore International Institute of Cardiac Sciences a unit of Asia Heart Foundation firmly believes in its mission quotan equitable distribution of quality health care for one and allquot This hospital represents a part of the dream to create a chain of cardiac care hospitals accessible to everyone

Conceptualized by DrDevi Shetty RTIICS has ushered in hope for the multitude of cardiac patients in the eastern part of the country and beyond
India has highest oral cancer cases tobacco guilty areca nut too

India has the dubious distinction of having the worlds largest number of oral cancer patients with an annual agestandardised incidence of 125 per 100000 says Dr Pankaj Chaturvedi Associate Professor Department of Head and Neck Oncology Tata Memorial Hospital Mumbai Oral cancer accounts for 94 per cent of all cancers in India oral cancer is not ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More